0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Endovascular treatment of patients with high-risk symptomatic intracranial vertebrobasilar stenoses: long - term outcomes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and purpose

          We present the long-term outcome after endovascular treatment of symptomatic intracranial posterior circulation stenoses.

          Methods

          30 patients with symptomatic intracranial posterior circulation stenoses exceeding 70% underwent endovascular treatment between 2006 and 2012. Data regarding presentation, follow-up, procedure details, complications and imaging follow-up were reviewed. All surviving patients underwent a phone interview to establish their current Modified Ranking Scales (MRS).

          Results

          Stenoses of the intracranial vertebral artery (24 patients) and basilar artery (6 patients) were treated with stents (10 patients), angioplasty alone (13 patients) or both (5 patients). Two procedures failed. One patient (3.3%) died after the procedure, two had stroke (6.6%) and one a subarachnoid haemorrhage without ensuing deficit. Two patients (6.7%) had asymptomatic complications (dissection and pseudoaneurysm). The median clinical follow-up time was 7 years. Of the 29 patients who survived the procedure, 6 died due to unrelated causes. Three patients (10%) had recurrent strokes and two (6.7%) a transient ischaemic attack in the posterior circulation. Two patients had subsequent middle cerebral artery strokes. Five (16.7%) patients had recurrent stenoses and three (10%) occlusions of the treated artery. Retreatment was performed in six patients, three (10%) with PTA and three (10%) with stenting. Current MRS scores were as follows: nine MRS 0, eight MRS 1, four MRS 2 and one MRS 4.

          Conclusions

          Long-term follow-up after endovascular treatment of high-risk symptomatic intracranial posterior circulation stenoses shows few stroke recurrences. Treatment of intracranial vertebral artery stenosis may be beneficial in appropriately selected patients.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: not found

          Stenting versus aggressive medical therapy for intracranial arterial stenosis.

          Atherosclerotic intracranial arterial stenosis is an important cause of stroke that is increasingly being treated with percutaneous transluminal angioplasty and stenting (PTAS) to prevent recurrent stroke. However, PTAS has not been compared with medical management in a randomized trial. We randomly assigned patients who had a recent transient ischemic attack or stroke attributed to stenosis of 70 to 99% of the diameter of a major intracranial artery to aggressive medical management alone or aggressive medical management plus PTAS with the use of the Wingspan stent system. The primary end point was stroke or death within 30 days after enrollment or after a revascularization procedure for the qualifying lesion during the follow-up period or stroke in the territory of the qualifying artery beyond 30 days. Enrollment was stopped after 451 patients underwent randomization, because the 30-day rate of stroke or death was 14.7% in the PTAS group (nonfatal stroke, 12.5%; fatal stroke, 2.2%) and 5.8% in the medical-management group (nonfatal stroke, 5.3%; non-stroke-related death, 0.4%) (P=0.002). Beyond 30 days, stroke in the same territory occurred in 13 patients in each group. Currently, the mean duration of follow-up, which is ongoing, is 11.9 months. The probability of the occurrence of a primary end-point event over time differed significantly between the two treatment groups (P=0.009), with 1-year rates of the primary end point of 20.0% in the PTAS group and 12.2% in the medical-management group. In patients with intracranial arterial stenosis, aggressive medical management was superior to PTAS with the use of the Wingspan stent system, both because the risk of early stroke after PTAS was high and because the risk of stroke with aggressive medical therapy alone was lower than expected. (Funded by the National Institute of Neurological Disorders and Stroke and others; SAMMPRIS ClinicalTrials.gov number, NCT00576693.).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial.

            Intracranial stenosis is one of the most common etiologies of stroke. To our knowledge, no randomized clinical trials have compared balloon-expandable stent treatment with medical therapy in symptomatic intracranial arterial stenosis.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis

                Bookmark

                Author and article information

                Journal
                Stroke Vasc Neurol
                Stroke Vasc Neurol
                svnbmj
                svn
                Stroke and Vascular Neurology
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2059-8696
                December 2019
                2 June 2019
                : 4
                : 4
                : 182-188
                Affiliations
                [1 ] departmentNeuroradiology , Medical University of Innsbruck , Innsbruck, Austria
                [2 ] departmentDepartment of Neuroradiology , Oxford University Hospitals NHS Foundation Trust , Oxford, UK
                [3 ] departmentDepartment of Neuroradiology , Centro Hospitalar Gaia/Espinho , Vila Nova de Gaia, Portugal
                [4 ] departmentDepartment of Clinical Neurosciences , University of Oxford , Oxford, UK
                [5 ] departmentNeurology , Stoke Mandeville Hospital , Aylesbury, Buckinghamshire, UK
                Author notes
                [Correspondence to ] Dr Wilhelm Küker; wilhelm.kueker@ 123456ouh.nhs.uk
                Author information
                http://orcid.org/0000-0002-1739-6115
                Article
                svn-2019-000230
                10.1136/svn-2019-000230
                6979875
                f4a073f0-042c-441c-b780-391cbc166557
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 13 January 2019
                : 23 March 2019
                : 30 April 2019
                Funding
                Funded by: National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC);
                Categories
                Original Research
                1506
                Custom metadata
                unlocked

                stent,angioplasty,atherosclerosis
                stent, angioplasty, atherosclerosis

                Comments

                Comment on this article